Emily L. Rapalino
Goodwin Procter LLPGeneral
Experience18 yrs
Elite Ratings
--
Practice Areas
Chemical Biotech (8 cases)
Biotech (78 cases)
Chemical (4 cases)
Communications (1 case)
Design (1 case)
Ratings
Experience
Grade
Trend
DCT
L3
D
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00085 | Regeneron Pharma Inc v. Sandoz Inc | 09/13/24 | Challenger | |
| 1:24-CV-00621 | Pfizer Inc v. Apotex Inc | 05/23/24 | Challenger | |
| 1:24-MD-03103 | In Re: Aflibercept Patent Litigation | 04/11/24 | ||
| 1:23-CV-01332 | AbbVie Inc v. Aurobindo Pharma USA Inc | 11/20/23 | Challenger | |
| 1:23-CV-01286 | Harmony Biosciences LLC v. Lupin Ltd | 11/09/23 | Challenger | |
| 1:22-CV-01423 | AbbVie Inc v. Alkem Laboratories Ltd | 10/27/22 | Challenger | |
| 2:22-CV-03044 | Aragon Pharma Inc v. Sandoz Inc | 05/24/22 | ||
| 1:20-CV-01423 | Otsuka Pharmaceutical Co Ltd v. Teva Pharma USA Inc | 10/23/20 | ||
| 1:20-CV-00804 | Sanofi Aventis US LLC v. Apotex Corp | 06/12/20 | ||
| 2:20-CV-03117 | Merck Sharp & Dohme BV v. Sandoz Inc | 03/20/20 | Challenger |